1. Academic Validation
  2. 5+1-Heterocyclization as preparative approach for carboxy-containing triazolo[1,5-c]quinazolines with anti-inflammatory activity

5+1-Heterocyclization as preparative approach for carboxy-containing triazolo[1,5-c]quinazolines with anti-inflammatory activity

  • Eur J Med Chem. 2024 Jan 11:266:116137. doi: 10.1016/j.ejmech.2024.116137.
Natalya Krasovska 1 Galina Berest 2 Igor Belenichev 2 Hanna Severina 3 Inna Nosulenko 2 Oleksii Voskoboinik 4 Sergiy Okovytyy 5 Serhii Kovalenko 5
Affiliations

Affiliations

  • 1 Community Company "Prymula", Metalurgiv av, 7, Zaporizhzhia, 69032, Ukraine.
  • 2 Zaporizhzhia State Medical and Pharmaceutical University, 26 Mayakovski Av, Zaporizhzhia, 69035, Ukraine.
  • 3 National University of Pharmacy, Pushkinska str., 53, Kharkiv, 61002, Ukraine.
  • 4 National University «Zaporizhzhia Polytechnic», Zhukovskyi st. 64, Zaporizhzhia, Ukraine. Electronic address: [email protected].
  • 5 Oles Honchar Dnipro National University, 72, Gagarin Avenue, Dnipro, 49010, Ukraine.
Abstract

Present article is devoted to the purposeful search of novel anti-inflammatory agents among carboxyl-containing partially hydrogenated [1,2,4]triazolo[1,5-с]quinazolines and products of their tandem cyclization. It has been shown that target compound's could be obtained via interaction between [2-(3-R-1H-1,2,4-triazol-5-yl)phenyl]amines and oxo-containing carboxylic acids and their esters of various structure. The structures of synthesized compounds were verified by appropriate methods, the features of NMR-spectra patterns were discussed as well. The low predicted toxicity of obtained compounds has been estimated using in silico methods. In vivo study on the model of acute aseptic inflammation (carrageenan test) have been revealed that synthesized compounds expose anti-inflammatory activity in the range of 0.94-52.66%. 4-(2-(Ethoxycarbonyl)-5,6-dihydro-[1,2,4]triazolo[1,5-c]quinazolin-5-yl)benzoic acid has been identified as most active compound. Additionally, the effects of some (2-R-5,6-dihydro[1,2,4]triazolo[1,5-c]quinazolin-5-yl)benzoic acids (compounds 3) on the levels of key inflammatory markers have been estimated. It has been shown that studied compounds decrease the level of neutrophils, COX-2, nitrotyrosine, IL-1b, C-reactive protein and increase level of eNOS. 4-(2-(Ethoxycarbonyl)-5,6-dihydro-[1,2,4]triazolo[1,5-c]quinazolin-5-yl)benzoic acid (3.2) has been identified as compound with most expressed anti-inflammatory activity and significant effect on the levels of marker of inflammatory processes. Molecular docking study towards СОХ-1 and СОХ-2 has been conducted to substantiate possible mechanism of obtained compounds anti-inflammatory activity. It has been found that fixation of 4-(2-(ethoxycarbonyl)-5,6-dihydro-[1,2,4]triazolo[1,5-c]quinazolin-5-yl)benzoic acid (3.2) molecule in active site of Enzyme is outstandingly similar to the reference ligands. The essential value of carboxylic group for presence of anti-inflammatory activity has been estimated as result of SAR-analysis. It has been found that studied class of compounds is perspective for further structural modification aimed to the creation of novel anti-inflammatory agents.

Keywords

5+1-heterocyclization; Anti-inflammatory activity; Carboxy-containing triazolo[1,5-c]quinazolines; Inflammation markers; Molecular docking; Predicted toxicity; SAR-analysis; [2-(3-R-1H-1,2,4-triazol-5-yl)phenyl]amines.

Figures
Products